Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exploration of molecular markers related to chemotherapy efficacy of hepatoid adenocarcinoma of the stomach.

Cellular oncology (Dordrecht, Netherlands) - 1 Apr 2024

Wei Jingtao, Ji Ke, Zhang Yue, Zhang Ji, Wu Xiaojiang, Ji Xin, Zhou Kai, Yang Xuesong, Lu Hongfeng, Wang Anqiang, Bu Zhaode

Abstract excerpt

PURPOSE: Preoperative neoadjuvant chemotherapy may not improve the prognosis of patients with hepatoid adenocarcinoma of the stomach (HAS), a rare pathological type of gastric cancer. Thus, the study aimed at the genomic and transcriptomic impacts of preoperative chemotherapy on HAS. METHODS: Patients with HAS who underwent surgical resection at Peking University Cancer Hospital were retrospectively included in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Exome Sequencing

Share to Gene Expression Regulation, Neoplastic

Share to Stomach Neoplasms

Share to Transcriptome

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 37943484
DOI: 10.1007/s13402-023-00892-9
PMCID: PMC12973988

Genes

ERBB2
FGFR2
HGF
MET
TP53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exploration of molecular markers related to chemotherapy efficacy of hepatoid adenocarcinoma of the stomach.PMID 37943484Read ↗

Hepatoid adenocarcinoma of the stomach and non-hepatoid alpha-fetoprotein-producing gastric cancer exhibit a high degree of molecular similarity.Semantic proximity Read ↗

Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomachSemantic proximity Read ↗

Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach.Semantic proximity Read ↗

Clinicopathological features and genomic profiles of hepatoid adenocarcinoma of the lung: Report of four cases.Semantic proximity Read ↗

Molecular profiling of hepatoid adenocarcinoma and adenocarcinoma with enteroblastic differentiation.Semantic proximity Read ↗

Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes.Semantic proximity Read ↗

Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival.Semantic proximity Read ↗

Analysis of perioperative chemotherapy-mediated genomic changes in gastric cancer.Semantic proximity Read ↗

Genomic landscape and potential therapeutic targets in alpha-fetoprotein-producing gastric cancer.Semantic proximity Read ↗

The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysisSemantic proximity Read ↗

Analysis of perioperative chemotherapy-mediated genomic changes in gastric cancerSemantic proximity Read ↗

Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.